Karyopharm Therapeutics Inc. (KPTI)
USD 0.66
(-0.65%)
USD 0.66
(-0.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 146.03 Million | 157.07 Million | 209.81 Million | 108.08 Million | 40.89 Million | 30.33 Million |
| Cost of Revenue | 4.94 Million | 5.21 Million | 3.4 Million | 2.7 Million | 2.4 Million | 161.37 Million |
| Gross Profit | 141.09 Million | 151.86 Million | 206.41 Million | 105.38 Million | 38.48 Million | -131.03 Million |
| Operating Expenses | 270.63 Million | 294.06 Million | 304.68 Million | 277.23 Million | 227.76 Million | 210.21 Million |
| Selling, General and Administrative Expenses | 131.88 Million | 145.4 Million | 143.84 Million | 126.41 Million | 105.42 Million | 48.84 Million |
| Research and Development Expenses | 138.75 Million | 148.66 Million | 160.84 Million | 150.81 Million | 122.34 Million | 161.37 Million |
| Other Expenses | - | -83 Thousand | -85 Thousand | 206 Thousand | -50 Thousand | -33 Thousand |
| Cost and Expenses | 275.57 Million | 299.27 Million | 308.09 Million | 279.93 Million | 230.16 Million | 210.21 Million |
| Operating Income | -129.53 Million | -142.2 Million | -98.27 Million | -171.85 Million | -189.27 Million | -179.88 Million |
| Interest Expense | 23.82 Million | 24.99 Million | 26.04 Million | 27.14 Million | 15.64 Million | 2.49 Million |
| Income Tax Expense | 323 Thousand | 369 Thousand | 268 Thousand | 309 Thousand | 40 Thousand | 26 Thousand |
| Earnings before Tax | -142.77 Million | -164.92 Million | -123.82 Million | -195.96 Million | -199.55 Million | -178.38 Million |
| Net Income | -143.09 Million | -165.29 Million | -124.08 Million | -196.27 Million | -199.59 Million | -178.4 Million |
| Earnings Per Share Basic | -1.25 | -2.02 | -1.65 | -2.72 | -3.22 | -3.14 |
| Earnings Per Share Diluted | -1.25 | -2.02 | -1.65 | -2.72 | -3.22 | -3.14 |
| Weighted Average Shares Outstanding | 114.22 Million | 81.87 Million | 75.21 Million | 72.04 Million | 61.95 Million | 56.78 Million |
| Weighted Average Shares Outstanding (Diluted) | 114.22 Million | 81.87 Million | 75.21 Million | 72.04 Million | 61.95 Million | 56.78 Million |
| Gross Margin | 0.97 | 0.97 | 0.98 | 0.97 | 0.94 | -4.32 |
| EBIT Margin | -0.81 | -0.89 | -0.47 | -1.56 | -4.50 | -5.80 |
| Profit Margin | -0.98 | -1.05 | -0.59 | -1.82 | -4.88 | -5.88 |
| EBITDA | -118.42 Million | -139.3 Million | -96.98 Million | -167.85 Million | -182.92 Million | -175.15 Million |
| Earnings Before Tax Margin | -0.89 | -0.91 | -0.47 | -1.59 | -4.63 | -5.93 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 29.51 Million | 42.78 Million | 33.12 Million | 33.74 Million | 146.03 Million | 36 Million |
| Cost of Revenue | 1.3 Million | 1.55 Million | 1.99 Million | 1.56 Million | 5.47 Million | 911 Thousand |
| Gross Profit | 28.21 Million | 41.23 Million | 31.12 Million | 32.18 Million | 140.56 Million | 35.09 Million |
| Operating Expenses | 63.76 Million | 69.35 Million | 64.88 Million | 69.99 Million | 270.1 Million | 66.35 Million |
| Selling, General and Administrative Expenses | 27.63 Million | 31.07 Million | 29.54 Million | 30.68 Million | - | 30.8 Million |
| Research and Development Expenses | 36.13 Million | 38.28 Million | 35.34 Million | 39.3 Million | - | 35.55 Million |
| Other Expenses | - | 14.29 Million | 196 Thousand | -211 Thousand | -356 Thousand | 89 Thousand |
| Cost and Expenses | 65.06 Million | 70.9 Million | 66.88 Million | 71.55 Million | 275.57 Million | 67.26 Million |
| Operating Income | -26.28 Million | -28.12 Million | -33.75 Million | -37.8 Million | -129.53 Million | -31.26 Million |
| Interest Expense | -11.38 Million | 8.94 Million | 5.88 Million | 6.2 Million | 23.82 Million | 6.07 Million |
| Income Tax Expense | -28 Thousand | 67 Thousand | 71 Thousand | 130 Thousand | 323 Thousand | 12 Thousand |
| Earnings before Tax | -32.04 Million | 23.85 Million | -37.29 Million | -41.7 Million | -142.77 Million | -34.49 Million |
| Net Income | -32.07 Million | 23.79 Million | -37.36 Million | -41.83 Million | -143.09 Million | -34.5 Million |
| Earnings Per Share Basic | -0.26 | 0.20 | -0.32 | -0.36 | - | -0.30 |
| Earnings Per Share Diluted | -0.26 | -0.20 | -0.32 | -0.36 | - | -0.30 |
| Weighted Average Shares Outstanding | 125.01 Million | 121.02 Million | 115.45 Million | 114.77 Million | 114.22 Million | 114.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 125.01 Million | 154.42 Million | 115.45 Million | 114.77 Million | 114.22 Million | 114.4 Million |
| Gross Margin | 0.96 | 0.96 | 0.94 | 0.95 | 0.96 | 0.97 |
| EBIT Margin | -0.89 | -0.66 | -1.02 | -1.12 | - | -0.79 |
| Profit Margin | -1.09 | 0.56 | -1.13 | -1.24 | -0.98 | -0.96 |
| EBITDA | -26.28 Million | -28.02 Million | -33.67 Million | -37.73 Million | - | -28.42 Million |
| Earnings Before Tax Margin | -0.89 | -0.66 | -1.02 | -1.12 | -0.89 | -0.87 |
DSKIF
EIDPARRY
RS
CMGMF
OD6
ADROITINFO